Contraceptives Market Share

  • Report ID: 4635
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Contraceptives Market Share

North American Market Forecast   

The North America contraceptives market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The rising demand for contraceptive pills and growing awareness among people on various contraceptive options such as female condom, injectable contraceptives, and so on are estimated to boost the market growth during the forecast period. In a research survey conducted in the United States in the year 2022, it has been observed that around 80% or over 3-quarter of reproductive age females reported that they would favor having the availability of OTC birth control pills without having a prescription for the same. Also, the presence of a large population is anticipated to propel market growth. Furthermore, the number of unintended pregnancies especially in the teenage group is anticipated to augment regional growth. As per the data from the Centers for Disease Control and Prevention, nearly 14% of women aged 15-49 used contraceptive pills in the U.S. to prevent the risk of unwanted pregnancy during 2017-2018. In addition, the growth in Sexually Transmitted Diseases (STDs) and rising government awareness programs to tackle the burgeoning population is anticipated to favor the sales of contraceptives in the region. Rising commercialization of contraceptives by major key players along with expanding disposable income of the population is expected to impetus the growth of the global contraceptives market in the North America region.

APAC Market Statistics

On the other hand, the market in the Asia Pacific region is also estimated to grow with a significant share and hold a notable market share. The major factors attributed to the growth of the market are the rising population and the increased number of babies born each year. Also, the increased prevalence of sexually transmitted diseases among the teenage population is anticipated to favor market growth in the region. Favorable government policies including ‘Hum Do Humare Do’ by the Indian government are also projected to generate noteworthy revenue.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4635
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of contraceptives is estimated at USD 30.9 billion.

The contraceptives market size was over USD 29.44 billion in 2024 and is projected to cross USD 64.16 billion by the end of 2037, witnessing more than 6.3% CAGR during the forecast period i.e., between 2025-2037. Growing disposable income and rising world population along with elevating risks of abortion will boost the market growth.

North America is anticipated to hold largest industry share by 2037, driven by rising demand for contraceptive pills and growing awareness among people on various contraceptive options such as female condom, and injectable contraceptives.

The major players in the market include Novartis Pharmaceutical Corporation, Agile Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Piramal Group, Viatris Inc., Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample